Trial Profile
A Phase 3, Multi-Center Trial to Demonstrate the Safety and Efficacy of Repeat Treatment With PurTox® for the Treatment of Glabellar Rhytides ('Frown Lines')
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Mar 2014
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms PT-03b
- Sponsors Mentor
- 12 Mar 2014 New trial record